{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:24:34Z","timestamp":1792293874629,"version":"4.4.0"},"reference-count":245,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.smim.2019.101300","type":"journal-article","created":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T02:14:46Z","timestamp":1574475286000},"page":"101300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"special_numbering":"C","title":["Global virus outbreaks: Interferons as 1st responders"],"prefix":"10.1016","volume":"43","author":[{"given":"Ben X.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor N.","family":"Fish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2019.101300_bib0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.smim.2019.101300_bib0010","doi-asserted-by":"crossref","first-page":"29210","DOI":"10.1074\/jbc.273.44.29210","article-title":"Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes","volume":"273","author":"Au","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0015","doi-asserted-by":"crossref","first-page":"9837","DOI":"10.1073\/pnas.95.17.9837","article-title":"Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3","volume":"95","author":"Juang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0020","first-page":"2327","article-title":"Activation of interleukin-6 gene expression through the NF-kappa B transcription factor","volume":"10","author":"Libermann","year":"1990","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.smim.2019.101300_bib0025","doi-asserted-by":"crossref","first-page":"10193","DOI":"10.1073\/pnas.90.21.10193","article-title":"Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8","volume":"90","author":"Matsusaka","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0014-5793(98)01514-2","article-title":"Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7","volume":"441","author":"Sato","year":"1988","journal-title":"FEBS Lett."},{"key":"10.1016\/j.smim.2019.101300_bib0035","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/MCB.20.13.4814-4825.2000","article-title":"Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation","volume":"20","author":"Falvo","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.smim.2019.101300_bib0040","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cell.2007.05.019","article-title":"An atomic model of the interferon-beta enhanceosome","volume":"129","author":"Panne","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.smim.2019.101300_bib0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441","author":"Kato","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.smim.2019.101300_bib0050","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1128\/JVI.01488-13","article-title":"The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection","volume":"87","author":"Errett","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0055","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/j.1460-2075.1996.tb00444.x","article-title":"Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein","volume":"15","author":"Yan","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.smim.2019.101300_bib0060","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0092-8674(00)81443-9","article-title":"Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA","volume":"93","author":"Chen","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.smim.2019.101300_bib0065","doi-asserted-by":"crossref","first-page":"34133","DOI":"10.1074\/jbc.M304531200","article-title":"STATs dimerize in the absence of phosphorylation","volume":"278","author":"Braunstein","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0070","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1158\/1541-7786.MCR-14-0450","article-title":"Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes","volume":"12","author":"Fish","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.smim.2019.101300_bib0075","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1073\/pnas.87.21.8555","article-title":"ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains","volume":"87","author":"Fu","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0080","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1073\/pnas.92.9.3829","article-title":"Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3","volume":"92","author":"Qureshi","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0085","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1074\/jbc.M001748200","article-title":"DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites","volume":"276","author":"Ehret","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0090","doi-asserted-by":"crossref","first-page":"30127","DOI":"10.1074\/jbc.274.42.30127","article-title":"Activation of the p38 mitogen-activated protein kinase by type I interferons","volume":"274","author":"Uddin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0095","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1242\/jcs.02373","article-title":"MAP kinase-mediated phosphorylation of distinct pools of histone H3 at S10 or S28 via mitogen- and stress-activated kinase 1\/2","volume":"118","author":"Dyson","year":"2005","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.smim.2019.101300_bib0100","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1073\/pnas.0710907105","article-title":"Role of the Akt pathway in mRNA translation of interferon-stimulated genes","volume":"105","author":"Kaur","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0105","doi-asserted-by":"crossref","first-page":"D1040","DOI":"10.1093\/nar\/gks1215","article-title":"Interferome v2.0: an updated database of annotated interferon-regulated genes","volume":"41","author":"Rusinova","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.smim.2019.101300_bib0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Mangeat","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.smim.2019.101300_bib0115","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nsmb758","article-title":"Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome","volume":"11","author":"Yu","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.smim.2019.101300_bib0120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature06553","article-title":"Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu","volume":"451","author":"Neil","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.smim.2019.101300_bib0125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2009.08.039","article-title":"Tetherin inhibits HIV-1 release by directly tethering virions to cells","volume":"139","author":"Perez-Caballero","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.smim.2019.101300_bib0130","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1261\/rna.035949.112","article-title":"A structure-based model of RIG-I activation","volume":"18","author":"Kolakofsky","year":"2012","journal-title":"RNA"},{"key":"10.1016\/j.smim.2019.101300_bib0135","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1243","article-title":"IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction","volume":"6","author":"Kawai","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0140","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","article-title":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses","volume":"5","author":"Yoneyama","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0145","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.celrep.2015.04.047","article-title":"DDX60 is involved in RIG-I-dependent and independent antiviral responses, and its function is attenuated by virus-induced EGFR activation","volume":"11","author":"Oshiumi","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.smim.2019.101300_bib0150","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1128\/MCB.01368-10","article-title":"DDX60, a DEXD\/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling","volume":"31","author":"Miyashita","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.smim.2019.101300_bib0155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virol.2007.01.038","article-title":"A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis","volume":"363","author":"Min","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.smim.2019.101300_bib0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jmb.2008.05.056","article-title":"Mechanism of PKR activation by dsRNA","volume":"381","author":"Lemaire","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.smim.2019.101300_bib0165","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.smim.2019.101300_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004048","article-title":"IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion","volume":"10","author":"Desai","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.smim.2019.101300_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001258","article-title":"Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus","volume":"7","author":"Huang","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.smim.2019.101300_bib0180","doi-asserted-by":"crossref","first-page":"42013","DOI":"10.1074\/jbc.M110.165936","article-title":"Transcription factor redundancy ensures induction of the antiviral state","volume":"285","author":"Schmid","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0185","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1128\/jvi.66.7.4470-4478.1992","article-title":"Constitutive expression of an ISGF2\/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection","volume":"66","author":"Pine","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0190","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1073\/pnas.0909144107","article-title":"ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells","volume":"107","author":"Zhao","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0195","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1101\/gad.1056303","article-title":"Protein ISGylation modulates the JAK-STAT signaling pathway","volume":"17","author":"Malakhova","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.smim.2019.101300_bib0200","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1128\/MCB.01466-09","article-title":"Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification","volume":"30","author":"Shi","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.smim.2019.101300_bib0205","doi-asserted-by":"crossref","first-page":"16151","DOI":"10.1074\/jbc.M209628200","article-title":"ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses","volume":"278","author":"Espert","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2010.10.008","article-title":"Antiviral activities of ISG20 in positive-strand RNA virus infections","volume":"409","author":"Zhou","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.smim.2019.101300_bib0215","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0076-6879(05)04055-3","article-title":"Assay and functional analysis of dynamin-like Mx proteins","volume":"404","author":"Kochs","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.smim.2019.101300_bib0220","doi-asserted-by":"crossref","first-page":"29893","DOI":"10.1074\/jbc.M115.681494","article-title":"Oligomerization and GTP-binding requirements of MxA for viral target recognition and antiviral activity against influenza A virus","volume":"290","author":"Nigg","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0225","doi-asserted-by":"crossref","first-page":"13445","DOI":"10.1128\/JVI.01682-12","article-title":"Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly","volume":"86","author":"Verhelst","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0230","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1089\/107999000750053762","article-title":"Caspase-dependent apoptosis by 2\u2032,5\u2032-oligoadenylate activation of RNase L is enhanced by IFN-beta","volume":"20","author":"Rusch","year":"2000","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.smim.2019.101300_bib0235","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1016\/S0021-9258(18)68878-7","article-title":"Characterization of 69- and 100-kDa forms of 2-5A-synthetase from interferon-treated human cells","volume":"263","author":"Hovanessian","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0240","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1074\/jbc.M305893200","article-title":"An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0245","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.immuni.2014.05.007","article-title":"Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor","volume":"40","author":"Zhu","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2019.101300_bib0250","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.chom.2007.06.009","article-title":"The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts","volume":"2","author":"Wang","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.smim.2019.101300_bib0255","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.smim.2019.101300_bib0260","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ni.2236","article-title":"SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates","volume":"13","author":"Lahouassa","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0265","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature10623","article-title":"HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase","volume":"480","author":"Goldstone","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.smim.2019.101300_bib0270","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm.3626","article-title":"The ribonuclease activity of SAMHD1 is required for HIV-1 restriction","volume":"20","author":"Ryoo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2019.101300_bib0275","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1073\/pnas.0509996103","article-title":"Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor","volume":"103","author":"Stremlau","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0280","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.chom.2009.04.006","article-title":"Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I","volume":"5","author":"Gack","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.smim.2019.101300_bib0285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/ni.1963","article-title":"ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses","volume":"12","author":"Hayakawa","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0290","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1126\/science.1074276","article-title":"Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein","volume":"297","author":"Gao","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.smim.2019.101300_bib0295","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/JVI.02649-13","article-title":"Beta interferon regulation of glucose metabolism is PI3K\/Akt dependent and important for antiviral activity against Coxsackie virus B3","volume":"88","author":"Burke","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0300","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature07815","article-title":"IFNalpha activates dormant haematopoietic stem cells in vivo","volume":"458","author":"Essers","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.smim.2019.101300_bib0305","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nm.1973","article-title":"Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion","volume":"15","author":"Sato","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2019.101300_bib0310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/mi.2012.46","article-title":"IFN-alpha-driven CCL2 production recruits inflammatory monocytes to infection site in mice","volume":"6","author":"Conrady","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0315","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0022-202X.2005.23803.x","article-title":"Type I interferons inhibit maturation and activation of mouse Langerhans cells","volume":"125","author":"Fujita","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.smim.2019.101300_bib0320","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1471-4159.2004.02487.x","article-title":"Regulation of RANTES\/CCL5 expression in human astrocytes by interleukin-1 and interferon-beta","volume":"90","author":"Kim","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.smim.2019.101300_bib0325","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<678::AID-IMMU678>3.0.CO;2-J","article-title":"Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha\/beta and interferon-gamma reveals MCP-3 heterogeneity","volume":"29","author":"Menten","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0330","doi-asserted-by":"crossref","first-page":"31119","DOI":"10.1074\/jbc.M604958200","article-title":"Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide","volume":"281","author":"Thomas","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0335","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cyto.2010.01.009","article-title":"Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"50","author":"Antonelli","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.smim.2019.101300_bib0340","doi-asserted-by":"crossref","first-page":"11917","DOI":"10.1073\/pnas.0502188102","article-title":"Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression","volume":"102","author":"Coelho","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0345","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature04606","article-title":"CD69 acts downstream of interferon-alpha\/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs","volume":"440","author":"Shiow","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.smim.2019.101300_bib0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001304","article-title":"Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice","volume":"7","author":"Seo","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.smim.2019.101300_bib0355","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20132183","article-title":"Type I IFN suppresses Cxcr2 driven neutrophil recruitment into the sensory ganglia during viral infection","volume":"211","author":"Stock","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2019.101300_bib0360","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.4049\/jimmunol.0903273","article-title":"Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites","volume":"184","author":"Xin","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0365","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2353\/ajpath.2009.090328","article-title":"Type I interferon modulates monocyte recruitment and maturation in chronic inflammation","volume":"175","author":"Lee","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.smim.2019.101300_bib0370","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1182\/blood-2007-11-125039","article-title":"CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR\/4E-BP1","volume":"111","author":"Murooka","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.smim.2019.101300_bib0375","doi-asserted-by":"crossref","first-page":"30219","DOI":"10.1074\/jbc.M403595200","article-title":"Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function","volume":"279","author":"Colvin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0380","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1073\/pnas.91.9.3652","article-title":"Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant","volume":"91","author":"Carr","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0385","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.2010.08152.x","article-title":"Monocytes\/macrophages but not T lymphocytes are the major targets of the CCL3\/CCL4 chemokines produced by CD38(+)CD49d(+) chronic lymphocytic leukaemia cells","volume":"150","author":"Zucchetto","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.smim.2019.101300_bib0390","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1189\/jlb.1104690","article-title":"Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2","volume":"78","author":"Sakamoto","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.smim.2019.101300_bib0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2478(97)00091-6","article-title":"Type I interferons enhance production of IFN-gamma by NK cells","volume":"59","author":"Hunter","year":"1997","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.smim.2019.101300_bib0400","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.4049\/jimmunol.169.8.4279","article-title":"Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection","volume":"169","author":"Nguyen","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0405","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.4049\/jimmunol.165.7.3571","article-title":"Distinct requirements for IFNs and STAT1 in NK cell function","volume":"165","author":"Lee","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0410","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.4049\/jimmunol.180.3.1592","article-title":"Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo","volume":"180","author":"Martinez","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0415","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.4049\/jimmunol.178.12.7540","article-title":"Type I IFN contributes to NK cell homeostasis, activation, and antitumor function","volume":"178","author":"Swann","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0420","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/clim.2000.4866","article-title":"Induction of Fas ligand-mediated apoptosis by interferon-alpha","volume":"95","author":"Kirou","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005969","article-title":"Correction: ISG15 regulates peritoneal macrophages functionality against viral infection","volume":"12","author":"Yanguez","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.smim.2019.101300_bib0430","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/107999004322813372","article-title":"The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells","volume":"24","author":"Pogue","year":"2004","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.smim.2019.101300_bib0435","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1189\/jlb.1005592","article-title":"IFN-alpha promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4","volume":"80","author":"Dauer","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.smim.2019.101300_bib0440","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4049\/jimmunol.161.4.1947","article-title":"Type I IFNs enhance the terminal differentiation of dendritic cells","volume":"161","author":"Luft","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0445","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.4049\/jimmunol.170.8.4069","article-title":"Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors","volume":"170","author":"Dauer","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0450","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/jlb.64.3.358","article-title":"Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells","volume":"64","author":"Paquette","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.smim.2019.101300_bib0455","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.20041964","article-title":"A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells","volume":"201","author":"Gautier","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2019.101300_bib0460","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.4049\/jimmunol.1101313","article-title":"Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing","volume":"188","author":"Simmons","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0465","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood.V99.9.3263","article-title":"Type I interferons produced by dendritic cells promote their phenotypic and functional activation","volume":"99","author":"Montoya","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.smim.2019.101300_bib0470","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nature03464","article-title":"IRF-7 is the master regulator of type-I interferon-dependent immune responses","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.smim.2019.101300_bib0475","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1189\/jlb.0603255","article-title":"Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells","volume":"74","author":"Izaguirre","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.smim.2019.101300_bib0480","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2567.2011.03412.x","article-title":"Regulation of effector and memory T-cell functions by type I interferon","volume":"132","author":"Huber","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.smim.2019.101300_bib0485","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.174.8.4465","article-title":"Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation","volume":"174","author":"Curtsinger","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0490","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2019.101300_bib0495","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.176.8.4525","article-title":"CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion","volume":"176","author":"Aichele","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0500","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.177.3.1746","article-title":"Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation","volume":"177","author":"Thompson","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0505","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.4049\/jimmunol.0900592","article-title":"Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory","volume":"183","author":"Agarwal","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0510","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.4049\/jimmunol.176.4.2074","article-title":"Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN","volume":"176","author":"Le Bon","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0515","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4049\/jimmunol.1000469","article-title":"Cutting edge: type I IFN reverses human Th2 commitment and stability by suppressing GATA3","volume":"185","author":"Huber","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0520","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.imbio.2008.07.022","article-title":"Interferon-alpha controls IL-17 expression in vitro and in vivo","volume":"213","author":"Moschen","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.smim.2019.101300_bib0525","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.2230460100","article-title":"Critical roles for IFN-beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor alpha","volume":"100","author":"Deonarain","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0530","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/intimm\/14.4.411","article-title":"IFN-alpha\/beta enhances BCR-dependent B cell responses","volume":"14","author":"Braun","year":"2002","journal-title":"Int. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0535","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1083\/jcb.123.6.1889","article-title":"Interferon-alpha induces the expression of the L-selectin homing receptor in human B lymphoid cells","volume":"123","author":"Evans","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.smim.2019.101300_bib0540","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.4049\/jimmunol.1700888","article-title":"Cutting edge: endogenous IFN-\u03b2 regulates survival and development of transitional B cells","volume":"199","author":"Hamilton","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0545","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.24557","article-title":"Neutralization of interferon-alpha\/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus","volume":"60","author":"Yao","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2019.101300_bib0550","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL","volume":"3","author":"Litinskiy","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0555","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20111644","article-title":"Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation","volume":"209","author":"Joo","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2019.101300_bib0560","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20032000","article-title":"TACI and BAFF-R mediate isotype switching in B cells","volume":"201","author":"Castigli","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2019.101300_bib0565","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1073\/pnas.0307348101","article-title":"Impaired IgA class switching in APRIL-deficient mice","volume":"101","author":"Castigli","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0570","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2019.101300_bib0575","doi-asserted-by":"crossref","first-page":"10877","DOI":"10.1128\/JVI.00949-10","article-title":"Chikungunya virus nonstructural protein 2 inhibits type I\/II interferon-stimulated JAK-STAT signaling","volume":"84","author":"Fros","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0580","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1128\/JVI.02712-13","article-title":"Enterovirus 2Apro targets MDA5 and MAVS in infected cells","volume":"88","author":"Feng","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001311","article-title":"The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling","volume":"7","author":"Mukherjee","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.smim.2019.101300_bib0590","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1073\/pnas.2335168100","article-title":"Inhibition of interferon signaling by dengue virus","volume":"100","author":"Munoz-Jordan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0595","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1128\/JVI.79.13.8004-8013.2005","article-title":"Inhibition of alpha\/beta interferon signaling by the NS4B protein of flaviviruses","volume":"79","author":"Munoz-Jordan","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0600","doi-asserted-by":"crossref","first-page":"9760","DOI":"10.1128\/JVI.01051-10","article-title":"Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex","volume":"84","author":"Rodriguez-Madoz","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0605","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/605847","article-title":"Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation","volume":"200","author":"Mazzon","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.smim.2019.101300_bib0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002550","article-title":"The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold","volume":"8","author":"Zhang","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.smim.2019.101300_bib0615","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.02349-05","article-title":"Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation","volume":"80","author":"Reid","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0620","doi-asserted-by":"crossref","first-page":"12289","DOI":"10.1073\/pnas.220398297","article-title":"The Ebola virus VP35 protein functions as a type I IFN antagonist","volume":"97","author":"Basler","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0625","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/JVI.02199-05","article-title":"Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha\/beta interferon production induced by RIG-I signaling","volume":"80","author":"Cardenas","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0630","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virol.2010.03.014","article-title":"Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta","volume":"402","author":"Bentz","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.smim.2019.101300_bib0635","doi-asserted-by":"crossref","first-page":"10040","DOI":"10.1128\/JVI.79.15.10040-10052.2005","article-title":"Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1","volume":"79","author":"Hahn","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0640","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/JVI.00602-08","article-title":"Epstein-Barr virus LF2: an antagonist to type I interferon","volume":"83","author":"Wu","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0645","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s13238-010-0141-8","article-title":"Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein","volume":"1","author":"Jiang","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.smim.2019.101300_bib0650","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.26064","article-title":"Hepatitis B virus polymerase impairs interferon-alpha-induced STAT activation through inhibition of importin-alpha5 and protein kinase C-delta","volume":"57","author":"Chen","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.smim.2019.101300_bib0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000986","article-title":"Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.smim.2019.101300_bib0660","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1096\/fj.02-0664fje","article-title":"IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3","volume":"17","author":"Bode","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2019.101300_bib0665","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.285.5424.107","article-title":"Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein","volume":"285","author":"Taylor","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.smim.2019.101300_bib0670","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1128\/JVI.01659-08","article-title":"MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3\/4A protease","volume":"83","author":"Baril","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0675","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS3\/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0680","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1128\/JVI.00533-12","article-title":"Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling","volume":"86","author":"Kumthip","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0685","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1128\/MCB.18.9.5208","article-title":"Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation","volume":"18","author":"Gale","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.smim.2019.101300_bib0690","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1073\/pnas.0600007103","article-title":"A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling","volume":"103","author":"Paulus","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0695","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1128\/JVI.00833-08","article-title":"Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO","volume":"82","author":"Huh","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0700","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1128\/JVI.79.6.3873-3877.2005","article-title":"Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production","volume":"79","author":"Taylor","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0705","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1128\/JVI.02489-08","article-title":"Essential role for either TRS1 or IRS1 in human cytomegalovirus replication","volume":"83","author":"Marshall","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0710","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005850","article-title":"Consecutive inhibition of ISG15 expression and ISGylation by cytomegalovirus regulators","volume":"12","author":"Kim","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.smim.2019.101300_bib0715","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/abbi.1999.1583","article-title":"HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms","volume":"373","author":"Cai","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.smim.2019.101300_bib0720","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00353-8","article-title":"HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability","volume":"12","author":"Stopak","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.smim.2019.101300_bib0725","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1128\/JVI.00853-08","article-title":"Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates","volume":"82","author":"Bartlett","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0730","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.virol.2009.11.018","article-title":"Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates","volume":"397","author":"Schaap-Nutt","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.smim.2019.101300_bib0735","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1128\/JVI.75.9.4283-4296.2001","article-title":"Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes","volume":"75","author":"Nees","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0740","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1101\/gad.12.13.2061","article-title":"Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity","volume":"12","author":"Ronco","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.smim.2019.101300_bib0745","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1128\/JVI.79.9.5353-5362.2005","article-title":"Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines","volume":"79","author":"Spann","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0750","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.virol.2008.01.022","article-title":"Attenuation of the type I interferon response in cells infected with human rhinovirus","volume":"374","author":"Kotla","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.smim.2019.101300_bib0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010428","article-title":"Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses","volume":"5","author":"Paladino","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2019.101300_bib0760","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.virol.2008.01.001","article-title":"Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling","volume":"374","author":"Johnson","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.smim.2019.101300_bib0765","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1073\/pnas.94.3.843","volume":"94","author":"He","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0770","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/JVI.02520-06","article-title":"Inhibition of cellular 2\u2032-5\u2032 oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein","volume":"81","author":"Sanchez","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013927","article-title":"Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling","volume":"5","author":"Jia","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2019.101300_bib0780","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/JVI.01265-06","article-title":"Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus","volume":"81","author":"Mibayashi","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0785","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1128\/JVI.80.8.3957-3965.2006","article-title":"The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target","volume":"80","author":"Twu","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0790","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1128\/JVI.74.13.6203-6206.2000","article-title":"Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication","volume":"74","author":"Bergmann","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0795","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1093\/emboj\/18.8.2273","article-title":"Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3\u2032-end processing machinery","volume":"18","author":"Chen","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.smim.2019.101300_bib0800","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1073\/pnas.0602184103","article-title":"The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2\u2032-5\u2032 oligo (A) synthetase\/RNase L pathway","volume":"103","author":"Min","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0805","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1128\/JVI.01142-06","article-title":"Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha\/beta interferon","volume":"80","author":"Dauber","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0810","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.virusres.2008.05.015","article-title":"Interferon antagonist function of Japanese encephalitis virus NS4A and its interaction with DEAD-box RNA helicase DDX42","volume":"137","author":"Lin","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.smim.2019.101300_bib0815","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1128\/JVI.02714-05","article-title":"Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism","volume":"80","author":"Lin","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0820","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1002\/pmic.201300001","article-title":"Proteomic analysis for Type I interferon antagonism of Japanese encephalitis virus NS5 protein","volume":"13","author":"Yang","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2019.101300_bib0825","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1073\/pnas.1016404108","article-title":"Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3\u2032 to 5\u2032 exonuclease activity essential for immune suppression","volume":"108","author":"Hastie","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0830","doi-asserted-by":"crossref","first-page":"12696","DOI":"10.1128\/JVI.00882-07","article-title":"Differential inhibition of type I interferon induction by arenavirus nucleoproteins","volume":"81","author":"Martinez-Sobrido","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0835","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1128\/JVI.00155-10","article-title":"Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus","volume":"84","author":"Zhou","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0840","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1128\/JVI.80.6.3009-3020.2006","article-title":"Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence","volume":"80","author":"Kash","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0845","doi-asserted-by":"crossref","first-page":"20661","DOI":"10.1073\/pnas.1213559109","article-title":"Structural basis for Marburg virus VP35-mediated immune evasion mechanisms","volume":"109","author":"Ramanan","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0850","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1128\/JVI.02575-10","article-title":"Marburg virus VP40 antagonizes interferon signaling in a species-specific manner","volume":"85","author":"Valmas","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0855","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virol.2011.12.011","article-title":"The nucleocapsid protein of measles virus blocks host interferon response","volume":"424","author":"Takayama","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.smim.2019.101300_bib0860","doi-asserted-by":"crossref","first-page":"8330","DOI":"10.1128\/JVI.00831-08","article-title":"STAT2 is a primary target for measles virus V protein-mediated alpha\/beta interferon signaling inhibition","volume":"82","author":"Ramachandran","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0865","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s13238-013-3096-8","article-title":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists","volume":"4","author":"Yang","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.smim.2019.101300_bib0870","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.1128\/JVI.01845-13","article-title":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist","volume":"87","author":"Niemeyer","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0875","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1128\/JVI.79.7.4451-4459.2005","article-title":"Mumps virus V protein antagonizes interferon without the complete degradation of STAT1","volume":"79","author":"Kubota","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0880","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1128\/JVI.78.11.5633-5641.2004","article-title":"Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively","volume":"78","author":"Shaw","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0885","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1128\/JVI.80.6.2675-2683.2006","article-title":"Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2","volume":"80","author":"Brzozka","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0890","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1128\/JVI.79.12.7673-7681.2005","article-title":"Identification of the rabies virus alpha\/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3","volume":"79","author":"Brzozka","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0895","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.1128\/JVI.00989-13","article-title":"The rabies virus interferon antagonist P protein interacts with activated STAT3 and inhibits Gp130 receptor signaling","volume":"87","author":"Lieu","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0900","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1128\/JVI.02498-06","article-title":"Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7","volume":"81","author":"Barro","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000280","article-title":"Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism","volume":"5","author":"Graff","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.smim.2019.101300_bib0910","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/cmi.2013.61","article-title":"Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain","volume":"11","author":"Siu","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.smim.2019.101300_bib0915","doi-asserted-by":"crossref","first-page":"16202","DOI":"10.1074\/jbc.M109.008227","article-title":"Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1\/IKKepsilon complex","volume":"284","author":"Siu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0920","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0603144103","article-title":"Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation","volume":"103","author":"Kamitani","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2019.101300_bib0925","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/JVI.02472-07","article-title":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells","volume":"82","author":"Narayanan","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0930","doi-asserted-by":"crossref","first-page":"11620","DOI":"10.1128\/JVI.00702-07","article-title":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain","volume":"81","author":"Wathelet","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0935","doi-asserted-by":"crossref","first-page":"32208","DOI":"10.1074\/jbc.M704870200","article-title":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus","volume":"282","author":"Devaraj","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2019.101300_bib0940","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1128\/JVI.01012-07","article-title":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum\/Golgi membrane","volume":"81","author":"Frieman","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0945","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1128\/JVI.76.10.5251-5259.2002","article-title":"Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus","volume":"76","author":"Xiang","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0950","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/jvi.67.3.1688-1692.1993","article-title":"The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms","volume":"67","author":"Davies","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0955","doi-asserted-by":"crossref","first-page":"11230","DOI":"10.1128\/JVI.74.23.11230-11239.2000","article-title":"The vaccinia virus soluble alpha\/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN","volume":"74","author":"Alcami","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0960","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1128\/JVI.01161-09","article-title":"The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling","volume":"84","author":"Laurent-Rolle","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0965","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1128\/JVI.79.3.1343-1350.2005","article-title":"West Nile virus inhibits the signal transduction pathway of alpha interferon","volume":"79","author":"Guo","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib0970","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.chom.2014.07.015","article-title":"The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon","volume":"16","author":"Laurent-Rolle","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.smim.2019.101300_bib0975","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.15252\/embr.201642627","article-title":"Zika virus inhibits type-I interferon production and downstream signaling","volume":"17","author":"Kumar","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.smim.2019.101300_bib0980","unstructured":"World Heath Organization. https:\/\/www.who.int, 2019 (accessed July 31, 2019)."},{"key":"10.1016\/j.smim.2019.101300_bib0985","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bpg.2009.10.012","article-title":"Adverse effects of drugs in the treatment of viral hepatitis","volume":"24","author":"Negro","year":"2010","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.smim.2019.101300_bib0990","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10620-010-1220-7","article-title":"Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C","volume":"55","author":"Dhillon","year":"2010","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.smim.2019.101300_bib0995","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000203639","article-title":"Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis","volume":"79","author":"Kim","year":"2009","journal-title":"Digestion"},{"key":"10.1016\/j.smim.2019.101300_bib1000","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2169\/internalmedicine.49.2656","article-title":"Distinct clinical courses in type 1 diabetes mellitus induced by peg-interferon-alpha treatment for chronic hepatitis C","volume":"49","author":"Yamazaki","year":"2010","journal-title":"Int. Med."},{"key":"10.1016\/j.smim.2019.101300_bib1005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2893.2003.00446.x","article-title":"Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1","volume":"10","author":"Formann","year":"2003","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.smim.2019.101300_bib1010","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa042608","article-title":"Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3","volume":"352","author":"Mangia","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2019.101300_bib1015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa066403","article-title":"ACCELERATE Investigators, Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3","volume":"357","author":"Shiffman","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2019.101300_bib1020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gut.2006.102558","article-title":"A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C","volume":"56","author":"Yu","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.smim.2019.101300_bib1025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.21975","article-title":"North-C Group, Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response","volume":"47","author":"Dalgard","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.smim.2019.101300_bib1030","first-page":"218","article-title":"Treatment of chronic hepatitis C genotype 4 with peginterferon alpha-2a plus ribavirin","volume":"56","author":"Varghese","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.smim.2019.101300_bib1035","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2019.101300_bib1040","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2019.101300_bib1045","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"PEGASYS International Study Group, Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.smim.2019.101300_bib1050","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/jmv.21583","article-title":"Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy","volume":"81","author":"Legrand-Abravanel","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.smim.2019.101300_bib1055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2893.2009.01182.x","article-title":"Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses","volume":"17","author":"Inoue","year":"2010","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.smim.2019.101300_bib1060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/523585","article-title":"Rapid virologic response: a new milestone in the management of chronic hepatitis C","volume":"46","author":"Poordad","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.smim.2019.101300_bib1065","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.15(6)2015.18640","article-title":"Rapid virological response represents the highest prediction factor of response to antiviral treatment in HCV-related chronic hepatitis: a multicenter retrospective study","volume":"15","author":"Federico","year":"2015","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.smim.2019.101300_bib1070","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2008.12.021","article-title":"Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV\/HIV infection","volume":"50","author":"Kim","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.smim.2019.101300_bib1075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gut.2007.129478","article-title":"Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C","volume":"57","author":"Persico","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.smim.2019.101300_bib1080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000025035","article-title":"Identification of a single nucleotide polymorphism in the MxA gene promoter (G\/T at nt \u201388) correlated with the response of hepatitis C patients to interferon","volume":"43","author":"Hijikata","year":"2000","journal-title":"Intervirology"},{"key":"10.1016\/j.smim.2019.101300_bib1085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1386-6346(02)00269-3","article-title":"The dinucleotide microsatellite polymorphism of the IFNAR1 gene promoter correlates with responsiveness of hepatitis C patients to interferon","volume":"25","author":"Matsuyama","year":"2003","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.smim.2019.101300_bib1090","doi-asserted-by":"crossref","first-page":"e6579","DOI":"10.1371\/journal.pone.0006579","article-title":"The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy","volume":"4","author":"Pang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2019.101300_bib1095","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/hep.22760","article-title":"Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B","volume":"49","author":"Brunetto","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.smim.2019.101300_bib1100","first-page":"425","article-title":"Efficacy and safety of peginterferon alpha-2a (40KD) in HBeAg-positive chronic hepatitis B patients","volume":"18","author":"Caruntu","year":"2009","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"10.1016\/j.smim.2019.101300_bib1105","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.2165\/11203660-000000000-00000","article-title":"Peginterferon-alpha-2a (40 kD): a review of its use in chronic hepatitis B","volume":"69","author":"Keating","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.smim.2019.101300_bib1110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-153-2-201007200-00256","article-title":"Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy","volume":"153","author":"Alric","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.smim.2019.101300_bib1115","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfq282","article-title":"Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient","volume":"25","author":"Kamar","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.smim.2019.101300_bib1120","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1038\/s41598-017-07434-y","article-title":"Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice","volume":"7","author":"van de Garde","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2019.101300_bib1125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nm1001","article-title":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques","volume":"10","author":"Haagmans","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2019.101300_bib1130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/jir.1996.16.489","article-title":"The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon","volume":"16","author":"Blatt","year":"1996","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.smim.2019.101300_bib1135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.1996.16.1","article-title":"Cell surface binding characteristics correlate with consensus type I interferon enhanced activity","volume":"16","author":"Klein","year":"1996","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.smim.2019.101300_bib1140","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2165\/00003495-200161110-00009","article-title":"IFN alfacon-1: a review of pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C","volume":"61","author":"Melian","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.smim.2019.101300_bib1145","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1001\/jama.290.24.3222","article-title":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study","volume":"290","author":"Loutfy","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.smim.2019.101300_bib1150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbrc.2008.04.006","article-title":"Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells","volume":"371","author":"Kumaki","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.smim.2019.101300_bib1155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3851\/IMP1477","article-title":"Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB\/c mice","volume":"20","author":"Kumaki","year":"2010","journal-title":"Antivir. Agents Chemother."},{"key":"10.1016\/j.smim.2019.101300_bib1160","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/infdis\/jis921","article-title":"Interferon \u03b2 therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever","volume":"208","author":"Smith","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.smim.2019.101300_bib1165","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/514310","article-title":"Evaluation of immune globulin and recombinant interferon-\u03b12b for treatment of experimental Ebola virus infections","volume":"179","author":"Jahrling","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.smim.2019.101300_bib1170","doi-asserted-by":"crossref","first-page":"207ra","DOI":"10.1126\/scitranslmed.3006605","article-title":"mABs and Ad-vectored IFN-\u03b1 therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms","volume":"5","author":"Qiu","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2019.101300_bib1175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004364","article-title":"A rapid screening assay identifies monotherapy with interferon-\u03b2 and combination therapies with nucleoside analogs as effective inhibitors of Ebola virus","volume":"10","author":"McCarthy","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.smim.2019.101300_bib1180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169255","article-title":"Interferon \u03b2-1a for the treatment of Ebola virus disease: a historically controlled, single-arm proof-of-concept trial","volume":"12","author":"Konde","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2019.101300_bib1185","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.3390\/v9050107","article-title":"A conserved residue, tyrosine (Y) 84, in H5N1 influenza A virus NS1 regulates IFN signaling responses to enhance viral infection","volume":"9","author":"Wang","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.smim.2019.101300_bib1190","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12864-019-5835-6","article-title":"West Nile virus infection and interferon alpha treatment alter the spectrum and the levels of coding and noncoding host RNAs secreted in extracellular vesicles","volume":"20","author":"Slonchak","year":"2019","journal-title":"BMC Genomics"},{"key":"10.1016\/j.smim.2019.101300_bib1195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/srep00259","article-title":"An orally available, small-molecule interferon inhibits viral replication","volume":"2","author":"Konishi","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2019.101300_bib1200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216139","article-title":"An interferon-like small chemical compound CDM-3008 suppresses hepatitis B virus through induction of interferon-stimulated genes","volume":"14","author":"Furutani","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2019.101300_bib1205","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.antiviral.2016.09.003","article-title":"Single dose of an adenovirus vectored mouse interferon-\u03b1 protects mice from lethal EV71 challenge","volume":"134","author":"Sun","year":"2016","journal-title":"Antiviral Res."},{"key":"10.1016\/j.smim.2019.101300_bib1210","first-page":"007","article-title":"Evaluation of different strategies for post-exposure treatment of Ebola virus infection in rodents","volume":"S1","author":"Richardson","year":"2011","journal-title":"J. Bioterror. Biodef."},{"key":"10.1016\/j.smim.2019.101300_bib1215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.05.004","article-title":"Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201)","volume":"108","author":"Dagley","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.smim.2019.101300_bib1220","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3390\/v6031410","article-title":"Single-dose intranasal treatment with DEF201 (adenovirus vectored consensus interferon) prevents lethal disease due to Rift Valley fever virus challenge","volume":"6","author":"Gowen","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.smim.2019.101300_bib1225","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/JVI.02485-14","article-title":"Profiling and characterization of influenza N1 strains potentially resistant to multiple neuraminidase inhibitors","volume":"89","author":"Baek","year":"2015","journal-title":"J. Virol."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532319300065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532319300065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:16:19Z","timestamp":1760915779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532319300065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":245,"alternative-id":["S1044532319300065"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2019.101300","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global virus outbreaks: Interferons as 1st responders","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2019.101300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101300"}}